Summary - A new market study, titled “Global Opioids Market Research Report Forecast to 2023” has been featured on WiseGuyReports.
Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. They are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses.
The main purpose of opioids is to treat conditions inducing chronic pain such as cancers, arthritis, lower back pain, and fibromyalgia. The market for opioids is increasing due to the growing geriatric population, coupled with an increasing focus on palliative care and technological advancements in opioids. However, drug misuse and addiction are likely to hamper the market growth over the forecast period.
The global opioids market is growing at a rapid pace. The global opioids market is expected to reach USD 29,535.80 million by 2023 from USD 19,554.49 million in 2017 and is expected to register a CAGR of 7.12% during the forecast period of 2018 to 2023.
In 2017, the market was led by the Americas with a 77.49% share, followed by Europe, and Asia-Pacific with shares of 10.69% and 8.1%, respectively.
The market has been segmented based on product, application, and end-user.
The global opioids market on the basis of product has been segmented into immediate-release/short-acting opioid and extended-release/long-acting opioid. Immediate-release/short-acting opioid is further sub-segmented into codeine, oxycodone, hydrocodone, fentanyl, morphine, propoxyphene, and others. Extended-release/long-acting opioid is further sub-segmented into oxycodone, hydrocodone, methadone, fentanyl, morphine, oxymorphone, and others. The extended-release opioid segment accounted for the larger market share of 65.21% in 2017, with a market value of USD 12,750.91 million; it is expected to register a CAGR of 6.96% during the forecast period.
The global opioids market on the basis of application has been segmented into pain relief and anesthesia. Pain relief is further sub-segmented into cancer pain, postoperative pain management, low-back pain, orthopedic pain, neuropathic pain, and fibromyalgia. Anesthesia is further sub-segmented into cough suppression, diarrhea suppression, and de-addiction. The pain relief segment accounted for the largest market share of 38.09% in 2017, with a market value of USD 7,448.51 million; it is expected to register a CAGR of 6.28% during the forecast period.
The global opioids market on the basis of end user has been segmented into hospitals and clinics, pharmacies, academic research institutes, and others. The hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period.
Key Players
Sanofi SA, Pfizer Inc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, Allergan Inc., Purdue Pharma L.P., West-Ward Pharmaceuticals Corporation, Sun Pharmaceutical Industries Ltd, Egalet Corporation, Janssen Global Services, LLC, Vertice Pharma LLC, and Mallinckrodt
Study Objectives
To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global opioids market
- To provide insights into factors influencing and affecting the market growth
- To provide historical and forecast revenue of market segments and sub-segments with respect to countries
- To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
- To provide economic factors that influence the global opioids market
- To provide a detailed analysis of the value chain and supply chain of the global opioids market
Target Audience
- Research and Development (R&D) Companies
- Pharmaceutical Companies
- Government Research Institutes
- Academic Institutes and Universities
- Research Laboratories
- Hospitals and Clinics
Key Findings
- The global opioids market is expected to reach USD 29,535.80 million by 2023 at a CAGR of 7.12% from 2018 to 2023
- The Americas accounted for the largest market share of 77.49% in 2017, with a market value of USD 15,151.87 million; the market is expected to register a CAGR of 6.72% during the forecast period. Europe was the second-largest market in 2017, valued at USD 2,091.00 million; the market is projected to exhibit a CAGR of 7.34%. However, the market in Asia-Pacific is expected to register the highest CAGR of 10.34%.
- On the basis of end user, the hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period. The pharmacies segment was the second-largest market in 2017, valued at USD 4,368.80 million; it is projected to exhibit a CAGR of 7.31%. However, the academic research institutes segment is expected to register the highest CAGR of 7.53%.
- On the basis of application, the anesthesia segment was the second-largest market in 2017, valued at USD 4,082.84 million; the market is projected to register the highest CAGR of 7.94%.
Regional Analysis
- Americas
o North America
US
Canada
o Latin America
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
- Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
- Middle East & Africa
o Middle East
o Africa
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/4255635-global-opioids-market-research-report-forecast-to-2023
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 2035002763 (UK)
Codeine is an opioid drug that used in around the clock treatment of mild to moderately severe pain.
Since it belongs to the group of long-acting opioids, it can prove to be habit-forming and its misuse can cause addiction and prescription drug overdose problems, so you should read all the facts related to it before you buy codeine online and utilize it in the treatment of your pain conditions.
Buy Codeine 15mg OnlineBuy Codeine 30mg OnlineBuy Codeine 300/30mg OnlineBuy Codeine 60mg Onlineorder here: https://adtrafficnow.info/product/codeine-30mg/
Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.” The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers.
The study also features a detailed analysis of the key drivers and trends related to this evolving domain.
Amongst other elements, the report includes: A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider, year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling, service(s) offered for proteome profiling, other service(s) offered, type of product profiled and type of sample(s) used.Detailed profiles of prominent proteome profiling players (shortlisted on the basis of the number of pipeline services).An analysis of the partnerships that have been established in this domain, in the recent past.A competitiveness analysis of proteome profiling services, featuring insightful pictorial summaries and representations.An elaborate discussion on various factors contributing to the high price of proteome profiling.A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework.A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):Application AreaDrug DiscoveryDisease DiagnosisOthers Type of Sponsor(s)Contract Research OrganizationsPharmaceutical CompaniesResearch and Academic Institutes Key Geographical RegionsNorth AmericaEuropeAsia-Pacific and the Rest of the World Key companies covered in the reportBiognosysBGIBioproximityCell Signaling TechnologyCreative BiolabsCreative ProteomicsCytomicsi-DNA BiotechnologyNMI TT PharmaservicesPoochon ScientificProteomics InternationalProteome FactorySciomicstebu-bioVProteomics For more information please click on the following link:https://www.rootsanalysis.com/reports/proteome-profiling-services.html Other Recent OfferingsPeptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030Peptide Therapeutics: Contract API Manufacturing Market, 2020 - 2030Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030 About Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.
The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
If you’d like help with your growing business needs, get in touch at [email protected] Contact InformationRoots Analysis Private LimitedGaurav Chaudhary+1 (415) 800 [email protected]
Global Opioids Market is anticipated to reach USD 34.96 billion by 2025.
However, when opioids are taken in high quantity it leads to risk of mortality and dependence in patients.
To treat severe and moderate pain opioids are mainly used.In addition, the prevalence of disease situations with long-lasting pain, such as cancer, arthritis, fibromyalgia, and lower back pain is propelling the market.
Significant increase in road accidents and trauma combined with repeatedly growing cases of surgical methods are driving the demand for opioid-based pain management solutions.
On the other hand, legalization and emergence of cannabis as a substitute to opioids obstruct the development of the opioids market and it is anticipated to grow at a significant CAGR of 4.8% in the upcoming period as the scope, product types, and its applications are increasing across the globe.Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/opioids-market/request-sampleOpioids Market may be explored by Product Outlook, applications, by dosage forms, and geography.
Opioids Market may be explored by Product Outlook as Immediate-Release/Short-Acting, could explored as (Codeine, Opioid, Oxycodone, Hydrocodone, Propoxyphene, Fentanyl, Hydroxymorphone, Morphine, Oxymorphone, Other IR), Extended-Release/Long-Acting Opioid could explore as (Methadone, Oxycodone, Fentanyl, Morphine, Oxymorphone, Hydromorphone, Tapentadol, Hydrocodone, Buprenorphine, Other ER).The “Extended-release/Long-Acting Opioid” segment dominated the market in 2016 and is anticipated to maintain its dominance by 2025 due to factors such as growth of innovative dose distributers such as high usage of these constituents for chronic pain organization and transdermal patches.
Market Analysis The global antipsychotic drugs market is touted to touch USD 18.5 billion at a staggering 5.7% CAGR over the predicted years (2021-2027).
Due of lack of insight, the person is unaware that he/she is acting and thinking strangely.
These drugs are used to treat common psychotic disorders including bipolar disorder, delusions, hallucinations, schizophrenia and others.Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/2784There are many factors that is driving the growth of the antipsychotic drugs market.
Some of these factors as per the Market Research Future (MRFR) report include increasing number of people suffering from schizophrenia, increasing prevalence of psychotic disorders, over prescription of antipsychotic drugs, increased drug abuse, antipsychotic drug addiction, and huge funds being invested on R activities, and introduction of novel antipsychotic compounds.
The antipsychotic drugs market report highlights crucial details about organizations operating across North America, Europe, Asia-Pacific (APAC), and the rest of the world regional markets.
This open-label research tested the short-term efficacy and resistance of lumateperone, which was modified from prior antipsychosis of external patients who had healthy schizophhrenia.Key Players Leading players profiled in the antipsychotic drugs market include Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca, Pfizer Inc., Bristol-Myers Squibb, Eli Lilly & Co. and others.
Market Research Future recently published ICP-OES Spectrometer Market Research Report - Global Forecast till 2025, Concentrates On Restraints, Reimbursement Policies, Technological Advancements, competitive outlookICP-OES Spectrometer Market Analysis Global ICP-OES spectrometer market was valued at USD 521.4 million in 2018 and is likely to grow at a 7.2% CAGR between 2019- 2025, according to the new report by Market Research Future (MRFR).
Read more news on: https://www.medgadget.com/2019/08/icp-oes-spectrometer-market-size-historical-analysis-emerging-technologies-trends-and-industry-set-for-rapid-growth-with-7-2-of-cagr-by-forecast-2025.htmlOn the contrary, the need for huge capital investment to set up instrument manufacturing plants and the soaring price of instruments are factors that may impede the global ICP-OES spectrometer market growth over the forecast period.
Besides, the grave effect of the ongoing COVID-19 pandemic is also impacting the market growth.
ICP-OES Spectrometer Market Key Players Eminent players profiled in the global ICP-OES spectrometer market report include Merck KGaA (Germany), Hitachi High-Technologies Corporation (Japan), FPI (China), Beijing Huake Tiancheng Technology Co., Ltd (China), Skyray Instrument Inc. (US), Horiba (Japan), Analytik Jena AG (Germany), Teledyne Leeman Labs (US), SPECTRO Analytical Instruments GmbH (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific (US), GBC Scientific Equipment (Australia), Shimadzu Corporation (Japan), and PerkinElmer Inc. (US), among others.
Meanwhile, the simultaneous segment is likely to grow at a fast pace for its increasing adoption rate.
By application, the global ICP-OES spectrometer market is segmented into food and agriculture, environmental testing, drug discovery, nanotechnology, and others.
